| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 29, 2019 | Feb 18, 2022 | Phathom Pharmaceuticals, Inc. | Director | Buy | 95.0 | +9,798 | 100.00% | ✗ | $186.2K |
| Jun 9, 2020 | Jun 11, 2020 | Avalo Therapeutics, Inc. | CEO | Buy | 97.5 | +100,000 | 132.02% | ✗ | $250K |